Showing results (1731-1740 of 2,009) with videos related to

Sort By:
Pageof 201
Scientific Reports|September 23, 2017
Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor CellsGuruchandar Arulmozhivarman, Martin Kräter, Manja Wobus, et al.
Oncoimmunology|November 11, 2017
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor modelElham Pishali Bejestani, Marc Cartellieri, Ralf Bergmann, et al.
Frontiers in Aging Neuroscience|December 5, 2022
Gait variability predicts cognitive impairment in older adults with subclinical cerebral small vessel diseasePeter Mukli, Sam Detwiler, Cameron D Owens, et al.
Leukemia|July 19, 2022
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemiaMaximilian A Röhnert, Michael Kramer, Jonas Schadt, et al.
Research Square|June 9, 2023
Lifetime of ground conformational state determines the activity of structured RNARhese D Thompson, Derek L Carbaugh, Joshua R Nielsen, et al.
Human Mutation|November 27, 2021
Recommendations by the ClinGen Rett/Angelman-like expert panel for gene-specific variant interpretation methodsDianalee McKnight, Lora Bean, Izabela Karbassi, et al.
L'Encephale|February 27, 2017
[What can we expect from clinical trials in psychiatry?]A Marsot, Q Boucherie, F Kheloufi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 9, 2003
Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparationsE Schleyer, S Pursche, C H Köhne, et al.
Oncoimmunology|November 11, 2017
Targeting IL-5Rα with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancerMichel Paquette, Luis-Guillermo Vilera-Perez, Simon Beaudoin, et al.
The Journal of Pathology|June 8, 2018
The iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancersSandrine Tury, Franck Assayag, Florian Bonin, et al.
Pageof 201